References
- Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque:part I:evolving concepts. J Am Coll Cardiol. 2005;46:937–954.
- Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519.
- Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
- Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515–581.
- Burke RJ, Chang C. Diagnostic criteria of acute rheumatic fever. Autoimmun Rev. 2014;13:503–507.
- Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun. 2000;68:688–693.
- Jack DL, Klein NJ, Turner MW. Mannose-binding lectin:targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev. 2001;180:86–99.
- Nedovic B, Posteraro B, Leoncini E, et al. Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta-analysis. Biomed Res Int. 2014 [cited 2017 Mar 10];2014:[738298]. DOI:10.1155/2014/738298
- Garred P, Larsen F, Seyfarth J, et al. Mannose-bindinglectin and its genetic variants. Gen Immun. 2006;7:85–94.
- Vardar F, Pehlivan S, Onay H, et al. Association between mannose binding lectin polymorphisms and predisposition to bacterial meningitis. Turk J Pediatr. 2007;49:270–273.
- Akcali A, Pehlivan S, Pehlivan M, et al. Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients. J Int Med Res. 2010;38:69–77.
- Ezekowitz RAB. Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity. Am J Hum Genet. 1998;62:6–9.
- Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology. 1998;199:327–339.
- Hegele RA, Busch CP, Young TK, et al. Mannose-binding lectin gene variation and cardiovascular disease in Canadian Inuit. Clin Chem. 1999;45(8 Pt 1):1283–1285.
- Madsen HO, Videm V, Svejgaard A, et al. Association of mannose-binding lectin deficiency with severe atherosclerosis. Lancet. 1998;352:959–960.
- Ramasawmy R, Spina GS, Fae KC, et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vaccine Immunol. 2008;15:932–936.
- Schafranski MD, Pereira Ferrari L, Scherner D, et al. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008;45:3827–3831.
- Garred P, Madsen HO, Marquart H, et al. Two edged role of mannose binding lectin inrheumatoid arthritis: a cross sectional study. J Rheumatol. 2000;27:26–34.
- Zhang C, Zhu J, Li SL, et al. The association of mannose-binding lectin genetic polymorphisms with the risk of rheumatoid arthritis: a meta-analysis. J Recept Signal Transduct Res. 2015;35(4):357–62.
- Rugonfalvi-Kiss S, Dosa E, Madsen HO, et al. High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose binding lectin genotype. Stroke. 2005;36:944–948.
- Vaudo G, Marchesi S, Gerli R, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis. 2004;63:31–35.
- Yki-Jarvinen H, Bergholm R, Leirisalo-Repo M. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis. 2003;62:630–634.
- Chan SY, Mancini GB, Kuramoto L, et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary arterydisease. J Am Coll Cardiol. 2003;42:1037–1043.
- Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease:cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol. 2010;30:17–23.
- Orsatti CL, Nahas EAP, Nahas-Neto J, et al. Mannose-binding lectin gene polymorphism and risk factors for cardiovascular disease in postmenopausal women. Mol Immunol. 2014;61:23–27.
- Chen Z, Sakuma M, Zago AC, et al. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:709–714.
- Müller II, Müller KAL, Schönleber H, et al. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS ONE. 2012 [cited 2017 Mar 10];7(6):[e38376]. DOI:10.1371/journal.pone.0038376
- Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants andcirculating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52:3020–3029.
- Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. Clin Exp Rheumatol. 2010;28:68–72.
- Lehmann LE, Schroeder S, Hartmann W, et al. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg. 2006;30:59–63.
- Herder C, Illig T, Baumert J, et al. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis. 2008;200:380–388.